首页> The Journal of Infectious Diseases> Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

导出原文传递

翻译打印收藏纠错

作者： et al. ^[1]

作者单位： Department of Biology and Technology, S. Raffaele Scientific Institute, Milan, Italy. ^[1]

关键词 HIV Antibodies HIV Infections HIV Seronegativity HIV-1 Histocompatibility Antigens Class I HIV抗体 HIV感染 HIV血清阴性组织相容性抗原Ⅰ类物质滥用静脉内 T淋巴细胞辅助诱导

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Infectious Diseases

1996年173卷2期

472-476页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

The Journal of Infectious Diseases

1996年173卷2期

472-476页

检索历史清除

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

The Journal of Infectious Diseases

相似文献

The Journal of Infectious Diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

The Journal of Infectious Diseases

相似文献

The Journal of Infectious Diseases

相关期刊

检索历史清除